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Abstract
Background: Cancer patients usually undergo extensive and debilitating treatments, which make
quality of life (QoL) and patient satisfaction important health care assessment measures. However,
very few studies have evaluated the relationship between QoL and patient satisfaction in oncology.
We investigated the clinical, demographic and QoL factors associated with patient satisfaction in a
large heterogeneous sample of cancer patients.
Methods: A cohort of 538 cancer patients treated at Cancer Treatment Centers of America®
(CTCA) was assessed. A patient satisfaction questionnaire developed in-house by CTCA was used.
It covered the following dimensions of patient satisfaction: hospital operations and services,
physicians and staff, and patient endorsements for themselves and others. QoL was assessed using
the European Organization for the Research and Treatment of Cancer Quality of Life
Questionnaire (QLQ-C30). The clinical, demographic and QoL factors were evaluated for
predictive significance using univariate and multivariate logistic regression.
Results: The mean age of our patient population was 54.1 years (SD = 10.5, range 17-86), with a
slight preponderance of females (57.2%). Breast cancer (n = 124) and lung cancer (n = 101) were
the most frequent cancer types. 481 (89.4%) patients were "very satisfied" with their overall
experience. Age and several QoL function and symptom scales were predictive of overall patient
satisfaction upon univariate analysis. In the multivariate modeling, only those with a score above
the median on the fatigue measure (i.e. worse fatigue) had reduced odds of 0.28 of being very
satisfied (p = 0.03).
Conclusion: Patient fatigue, as reported by the QoL fatigue scale, was an independent significant
predictor of overall patient satisfaction. This finding argues for special attention and programs for
cancer patients who report higher levels of fatigue given that fatigue is the most frequently reported
symptom in cancer patients.
Background
In recent years, awareness has risen of how patients per-
ceive the quality of their care [1,2]. In an extremely com-
petitive environment, patient satisfaction has become a
tool to gain attention and value amongst the patients as
well as providers. Hospitals and other health care centers
are increasingly using this information while making
important decisions regarding the operational and treat-
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ment plans [3]. The patient satisfaction data is the key
indicator of the quality of care and treatment delivered by
the physicians, paramedical staff and the hospital as a
whole [4]. The health centers can use survey results to
design and track quality improvement over time, as well
as compare themselves to other health centers. Also, this
information is of great use for healthcare accreditations.
By conducting their own surveys, the health care organiza-
tions are able to recognize and resolve potential patient
satisfaction problems and thus improve their strategies
[5,6]. Having satisfaction surveys also helps identify the
specific needs of the patients for the health care provider
[7].
The assessment of patient satisfaction in an oncology set-
ting is particularly salient. Advances in diagnostics, treat-
ment, supportive care and rehabilitation all necessitate
continued monitoring to determine whether patients are
satisfied with the increasingly complex and multidiscipli-
nary nature of health care services that they are receiving,
and to identify areas in which improvement is needed.
Cancer patients should be surveyed regularly due to the
usual extensive and debilitating treatments that they must
undergo. The modes of therapies have their own side
effects and often result in difficult patient compliance. As
a result, considerable demands are placed on health care
providers to satisfy the complex healthcare needs of can-
cer patients. Several studies have been done to study
patient satisfaction in cancers like gastro esophageal [8],
breast [5,9], colorectal [10], lung, prostate [11] and gyne-
cological [12,13]. But very few have dealt with a large sam-
ple size and a population that is heterogeneous with
respect to cancer types.
Similarly, a number of studies have been conducted to
evaluate the predictors of patient satisfaction in various
healthcare settings including oncology [14-18]. Patient
perceptions of needs met or emotional support provided
were predicted by their perceptions of the occurrence of
physician behaviors involving information such as the
diagnosis and tests and treatment [19]. Patient percep-
tions of physician behaviors were found to be stronger
predictors of patient satisfaction than the actual occur-
rence or absence of those behaviors [20]. A poorer prog-
nosis and a positive quality of the day's news were
associated with higher satisfaction. Use of the patient's
first name and attempts to establish privacy during an
exam were positively correlated with satisfaction, whereas
discussing the role of the family and tumor status had a
negative impact [21,22]. The number of nurses and doc-
tors per bed, institution size, geo-cultural origin, ward set-
ting, teaching/non-teaching setting, treatment toxicity,
global health status, participation in clinical trials and
education level were all associated significantly with satis-
faction. Doctor's and nurse's interpersonal skills, informa-
tion provision, and availability also influenced overall
satisfaction [23,24]. Common predictors of the overall
quality perception which the patients perceive as rela-
tively problematic aspects of care were 'was informed
about follow-up care after completing treatment', 'knew
next step in care', 'knew who to go to with questions', and
'providers were aware of test results'. The type of treatment
received and duration of disease also influenced the level
of patient satisfaction [25,26]. Moreover, patient satisfac-
tion can at times be affected by the resistance to the life-
style changes that a cancer diagnosis and treatment entails
and might not necessarily be a reflection of the patients'
perceptions of care with their healthcare providers. There
also have been a few studies that have indicated a possible
link between quality of life (QoL) and patient satisfaction
in cancer [27-31].
There is extensive data in the literature demonstrating the
use of QoL tools as important predictors of patient out-
comes such as survival [32-37]. QoL tools measuring the
activities of daily life can predict survival in several differ-
ent types of cancers independent of the extent of the dis-
ease and other clinical prognostic factors. These studies
have used different combinations of clinical and QoL fac-
tors in multivariate models evaluating the prognostic sig-
nificance of each on clinical outcomes. These studies have
used a variety of QoL tools to measure the activities of
daily living, the most commonly used instrument being
the European Organization for Research and Treatment of
Cancer Quality of Life Questionnaire (QLQ-C30).
In the light of above observations, we hypothesized that
QoL tools could predict patient satisfaction with the care
received in an oncology treatment setting. The goal of this
study was two fold: to describe the patients' experiences
with the care they receive and to investigate the clinical,
demographic and QoL factors associated with patient sat-
isfaction in a large heterogeneous sample of cancer
patients treated at a community hospital comprehensive
cancer center. For the purpose of this study, the definition
of QoL was based on criteria in the QLQ-C30 question-
naire, which focuses on the patient's capacity to fulfill the
activities of daily living.
Methods
Study Population
A cohort of 538 cancer patients treated at Cancer Treat-
ment Centers of America® (CTCA) at Midwestern Regional
Medical Center (MRMC) and Cancer Treatment Centers of
America®  at Southwestern Regional Medical Center
(SRMC) between August 2006 and December 2007 was
surveyed. All patients who had completed a treatment
plan consultation with a CTCA physician without having
undergone any treatment at CTCA were eligible to partic-
ipate in this study. Patients with all stages of all cancerBMC Health Services Research 2009, 9:190 http://www.biomedcentral.com/1472-6963/9/190
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types were eligible for the study. The study was approved
by the Institutional Review Boards at MRMC and SRMC.
Questionnaire
The questionnaire was first developed and implemented
by the Research team at CTCA in August 2006. The survey
was administered daily at both CTCA sites. An attempt
was made to approach all new patients onsite for survey
administration. Those who were not approached onsite
were sent a survey in the mail. The survey, return envelope
and a cover letter was provided in these mailings to the
patients.
In brief, our patient satisfaction questionnaire relates to
the following dimensions of patient satisfaction: hospital
operations and services, physicians and staff, and patient
endorsements for themselves and others. The majority of
the questions were measured on a five-point scale from
"Very dissatisfied" to "Very satisfied". The patients were
asked about their method of contact with our hospital as
well as the primary reason of their visit. Finally, the
patients were asked if our hospital met their expectations
and if they would bring their relatives and friends to the
hospital if needed.
QoL Assessment
QoL was assessed using QLQ-C30, which emphasizes a
patient's capacity to fulfill the activities of daily living. The
QLQ-C30 is a 30-item cancer specific questionnaire that
incorporates five functioning scales (physical, role, cogni-
tion, emotional, and social), nine symptom scales
(fatigue, pain, and nausea/vomiting, dyspnea, insomnia,
loss of appetite, constipation, diarrhea, financial prob-
lems), and a global health status/QoL scale. The raw
scores are linearly transformed to give standard scores in
the range of 0-100 for each of the functioning and symp-
tom scales. Higher scores in the global and functioning
scales and lower scores in the symptom scales indicate
better QoL. A difference of 5-10 points in the scores repre-
sents a small change, 10-20 points a moderate change and
greater than 20 points a large clinically significant change
from the patient's perspective [38]. This instrument has
been extensively tested for reliability and validity [39-41]
and is one of the most common QoL questionnaires in
cancer research.
Statistical Analysis
All data were analyzed using SPSS version 16.0 (SPSS,
Chicago, IL, USA). Descriptive statistics and frequencies
were computed for each item in the questionnaire. Stage
at diagnosis was categorized into 2 groups of stages I and
II (early stage) and stages III and IV (late stage). The prior
treatment history variable categorized the patients into
those who have received definitive cancer treatment else-
where before coming to our institution and those who
were newly diagnosed at our institution. Study patients
were dichotomized into two groups based on the median
scores for all QoL scales to yield "above median" and
"below median" scores. This was done to reduce multicol-
linearity between various QoL scales. The median score
was chosen arbitrarily as there are no established cutoffs
for QoL in cancer patients. A difference was considered to
be statistically significant if the p value was less than or
equal to 0.05. Distribution of patient satisfaction analyses
was based on a sample size of 538 while the predictors of
patient satisfaction analyses were based on a sample size
of 445 only. This is because QoL data was available for
only 445 out of 538 patients.
The available clinical factors and demographic variables,
as well as QoL, were evaluated for predictive significance
using either t-tests or chi-square tests, as appropriate. A
difference was considered to be statistically significant if
the p value was less than or equal to 0.05. The question
"Considering everything, how would you rate your overall
experience with CTCA" was used as the dependent varia-
ble. It was measured on a five-point scale from "Very dis-
satisfied" to "Very satisfied. For the purpose of this
analysis, it was dichotomized into 2 groups: "very satis-
fied" and all other categories combined into "not very sat-
isfied". Multivariate logistic regression analyses were then
performed to evaluate the joint prognostic significance of
those clinical, demographic and QoL factors that were
shown to be predictive in univariate analyses. In particu-
lar, QoL scales found to be significant upon univariate
analysis were evaluated for their association with patient
satisfaction both with and without controlling for the
clinical and demographic factors. Each QoL scale was
treated as a dichotomous variable for the purpose of uni-
variate and multivariate logistic regression analyses.
Results
Response Rate
A total of 2203 patients were contacted at both centers
combined to participate in the survey between August
2006 and December 2007 at their initial visit to CTCA.
However, only 538 patients responded. As a result, the
response rate for this study was 24.4%. 62.6% of surveys
were collected in-person; 37.4% via mail, with no differ-
ence in overall satisfaction by mode of data collection (p
= 0.3).
Baseline Patient Characteristics
Table 1 shows baseline patient characteristics. The mean
age of our patient population was 54.1 years (SD = 10.5,
range 17-86), with a slight preponderance of females
(57.2%). Breast cancer (n = 124, 23.0%) and lung cancer
(n = 101, 18.8%) were the most frequent cancer types
found in our study population.BMC Health Services Research 2009, 9:190 http://www.biomedcentral.com/1472-6963/9/190
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Patient Satisfaction Responses
Table 2 describes the level of patient satisfaction with
CTCA operations and services. 481 (89.4%) patients were
"very satisfied" with their overall experience with CTCA. A
high proportion of patients were "very satisfied" with
scheduling of their first visit (n = 475, 88.5%) and the
speed of admissions and registrations (n = 483, 89.8%).
Relatively smaller number of patients (n = 355, 67%)
were "very satisfied" with the amount of time they had to
wait for the appointments. Table 3 describes the level of
patient satisfaction with CTCA physicians and staff. All
physician satisfaction items had a "very satisfied" rating of
over 80%. Satisfaction with the staff was high with 92.9%
of the patients "very satisfied". Table 4 reports the patient
endorsement of CTCA for themselves and others. 468
(87%) patients said they would "definitely" bring their
mother, father or other loved ones to CTCA for treatment
while 459 (85.3%) patients said they were "extremely
likely" to recommend CTCA to friends and associates.
Univariate Analysis - Predictors of Patient Satisfaction
Table 5 describes the means, medians and standard devi-
ations of QLQ-C30 scale scores. Among the QLQ-C30
functioning scales, the emotional functioning scale had
the lowest (worst) mean score of 67.0 while the highest
(best) mean score of 79.3 was recorded for the cognitive
functioning scale. Among the QLQ-C30 symptom scales,
the nausea scale had the lowest (best) mean score of 10.4
while the highest (worst) mean score of 37.4 was recorded
for the fatigue scale.
Table 6 describes the univariate analysis of clinical and
demographic predictors of patient satisfaction. There were
no significant predictors of patient satisfaction as shown
in Table 6. The only significant predictor was age at diag-
nosis, with mean age of 49.3 years for "not very satisfied"
category and 54.0 years for "very satisfied" category (p =
0.008).
Table 7 displays the univariate analysis of QoL predictors
of patient satisfaction. The QoL functioning scales that
were found to be significant were global, physical, role
and social whereas the significant symptom scales were
fatigue, nausea, pain, appetite loss and financial difficulty.
Multivariate Analysis - Predictors of Patient Satisfaction
In the first multivariate logistic regression model with
only the QoL scores, only the fatigue score was a signifi-
cant predictor of patient satisfaction (Table 8). Patients
Table 1: Patient characteristics (N = 538)
Variable Categories N Percent
CTCA Site Midwestern 342 63.6
Southwestern 196 36.4
Gender Male 230 42.8
Female 308 57.2
Prior Treatment History Newly Diagnosed 235 43.7
Previously Treated 303 56.3
Tumor Type Breast 124 23.0
Lung 101 18.8
Colorectal 60 11.2
Prostate 58 10.8
Pancreas 46 8.7
Ovary 19 3.5
Others 130 24.2
Stage at Diagnosis I 55 10.2
II 134 24.9
III 115 21.4
IV 174 32.3
Unknown 60 11.2
Table 2: Patient satisfaction with CTCA operations and services
Item VD SD N SS VS
N%N%N%N % N %
Considering everything, how would you rate your overall experience with CTCA? 7 1.3 2 0.4 2 0.4 35 6.5 481 89.4
How satisfied were you with the convenience of your transportation arrangements? 1 0.2 7 1.3 26 4.8 43 8.0 415 77.1
How satisfied were you with the scheduling of your first visit to CTCA? 8 1.5 4 0.7 8 1.5 42 7.8 475 88.5
How satisfied were you with the speed of the registration process? 3 0.6 3 0.6 8 1.5 40 7.4 483 89.8
How satisfied were you with the amount of time you had to wait for appointments? 5 0.9 16 3.0 24 4.5 13 24.5 355 67.0
VD = Very Dissatisfied
SD = Somewhat Dissatisfied
N = Neutral
SS = Somewhat Satisfied
VS = Very SatisfiedBMC Health Services Research 2009, 9:190 http://www.biomedcentral.com/1472-6963/9/190
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reporting more fatigue had significantly lower satisfac-
tion. A patient reporting fatigue above the median (high
fatigue) had reduced odds of 0.28 of being "very satisfied"
compared to a patient with fatigue below the median (low
fatigue). Overall, the model was significant (chi-square =
23.05, 9 df, p = 0.006).
In the second multivariate logistic regression model none
of the demographic controls were significant (Table 9).
Fatigue remained significant with an odds ratio of 0.28, so
its effect was essentially unchanged when in a full model
with controls. Again, the model overall was also signifi-
cant (chi-square = 34.25, 19 df, p = 0.017). In Tables 8 and
9, "below median" is the reference category for all QoL
scales.
Discussion
Patient satisfaction measures aim to assess the extent to
which an individual's health care experiences match his or
her expectations. Patients' perceptions of their care are an
essential indicator of quality in health care and provide
important clinical information about the extent to which
a patient's needs and expectations are being met. We con-
ducted this study to assess patient satisfaction with care at
our cancer treatment hospital and determine its associa-
tion with self-reported QoL.
Table 3: Patient satisfaction with physicians and staff
Item VD SD N SS VS
N%N%N%N % N %
Helping you understand your medical condition 3 0.6 3 0.6 7 1.3 64 11.9 457 84.9
Explaining your treatment options to you 3 0.6 3 0.6 10 1.9 67 12.8 441 84.2
Time that you were able to spend with our doctor(s) 1 0.2 8 1.5 11 2.0 65 12.1 446 82.9
Overall satisfaction with our physicians 3 0.6 4 0.7 5 0.9 46 8.6 470 87.4
Our staff caring for you as an individual 3 0.6 4 0.7 5 0.9 26 4.9 496 92.9
VD = Very Dissatisfied
SD = Somewhat Dissatisfied
N = Neutral
SS = Somewhat Satisfied
VS = Very Satisfied
Table 4: Patient endorsement of CTCA for themselves and others
Item Categories N %
Will you return for treatment? No 6 1.1
Undecided 19 3.5
Yes 480 85.5
Would you bring your mother, father or other loved ones to CTCA for treatment? Definitely not 4 0.7
Probably not 1 0.2
Not Sure 6 1.1
Probably 45 8.4
Definitely 468 87.0
Will you recommend CTCA to friends and associates? Not at all likely 1 0.2
11 0 . 2
21 0 . 2
41 0 . 2
Neutral 3 0.6
75 0 . 9
81 7 3 . 2
94 3 8 . 0
Extremely Likely 459 85.3BMC Health Services Research 2009, 9:190 http://www.biomedcentral.com/1472-6963/9/190
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Numerous studies on patient satisfaction with care have
been conducted in an oncology setting. A study done in
91 patients with gastric and esophageal using the Euro-
pean Organization for Research and Treatment of Cancer
'satisfaction with in-hospital care' questionnaire (QLQ-
SAT32) found the highest scores reported for doctors,
nurses and overall satisfaction scales. The lowest scores
were reported for access to the hospital, and comfort and
cleanliness[8]. A study conducted in a prospective cohort
of 39 patients with recurrent gynecologic malignancies
receiving chemotherapy found that patient evaluation of
care is more closely related to the interpersonal aspects of
the health care provider relationship than it is to physical
symptoms [13]. A national survey conducted in cancer
patients in England for four common cancers: breast,
colorectal, lung and prostate (55,674 patients) found that
dissatisfaction was greater (p < 0.001) in younger and
female patients and breast cancer patients expressed least,
and prostate cancer patients expressed greatest dissatisfac-
tion[11].
Yet another study conducted using Patient Satisfaction
and Quality in Oncological Care (PASQOC)® question-
naire in a random sample of 3384 cancer patients found
that overall satisfaction was high, but specific reporting
questions revealed many areas for improvement such as
shared decision making, doctor-patient communication
and organization of care. Patient-provider relationship,
Table 5: Baseline QLQ-C30 scores of 445 cancer patients
QLQ-C30 Scale Mean Median Standard Deviation Range
Global 60.8 66.6 25.9 0-100
Physical 78.4 86.6 22.5 0-100
Role 69.6 83.3 33.2 0-100
Emotional 67 66.6 24.3 0-100
Cognitive 79.3 83.3 24.7 0-100
Social 70.8 83.3 31.3 0-100
Fatigue 37.4 33.3 27.8 0-100
Nausea/Vomiting 10.4 0.0 18.7 0-100
Pain 31.7 16.6 31 0-100
Dyspnea 21.4 0.0 28.6 0-100
Insomnia 37 33.3 32.4 0-100
Appetite Loss 33.4 0.0 30.6 0-100
Constipation 17.6 0.0 27.2 0-100
Diarrhea 12.28 0.0 22.6 0-100
Financial Difficulty 26.8 0.0 32.9 0-100
Table 6: Univariate analysis of clinical and demographic predictors of patient satisfaction
Variable Not very satisfied
(%)
Very satisfied
(%)
P - Value
Gender
Male 9.9 90.1 0.2
Female 6.6 93.4
Prior Treatment History
Newly diagnosed 5.7 94.3 0.2
Previously treated 9.8 90.2
Tumor Type
Breast 8.0 92.0
Colorectal 4.1 95.9
Lung 3.7 96.3
Ovary 0.0 100.0 0.1
Pancreas 17.9 82.1
Prostate 8.0 92.0
Other 10.8 89.2
Stage at Diagnosis
Early 6.2 93.8 0.4
Late 8.7 91.3
Age at Diagnosis (Mean) 49.3 years 54.0 years 0.008BMC Health Services Research 2009, 9:190 http://www.biomedcentral.com/1472-6963/9/190
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facility setting and information on diagnosis and treat-
ment options were major determinants of a patient's will-
ingness to recommend a facility to a friend or relative if
needed [42]. Some studies found information received,
technical competences, interpersonal and communica-
tion skills, time spent talking with doctors and nurses,
accessibility and coordination of care, waiting times, and
patients' emotional needs as important or priority areas to
improve cancer care services [7,43,44]. In yet another
study 'skills of nursing staff ', 'courtesy of nursing staff ',
'courtesy of people who drew blood' and 'cleanliness of
hospital in general' were sought predictors of patients'
overall perceptions of the quality of care [45].
We also evaluated the different determinants of patient
satisfaction. In this study, we found that patient fatigue, as
reported on the QoL fatigue scale, was a significant inde-
pendent predictor of patient satisfaction. This finding has
important implications for the care of new cancer patients
given that fatigue is the most frequently reported symp-
tom in cancer patients [46-51] with an estimated 60-96%
of cancer patients undergoing treatment experiencing
fatigue, including 60-93% of patients on radiotherapy
and 80-96% of patients on chemotherapy [50,52]. There
are several plausible mechanisms whereby increased
fatigue could lead to lowered satisfaction. Increased
fatigue may lead to a lowered capacity for tolerating nor-
mal issues that arise during care, such as the burden of
paperwork during registration, time waiting for appoint-
ments, or procedures that are somewhat lengthy. In addi-
tion, increased fatigue can lead to lack of concentration
and attention when interacting with medical personnel.
All of these factors can, in turn, lead to a lower level of
patient satisfaction.
Several studies in the literature have demonstrated the
adverse impacts of fatigue on physical, emotional, eco-
nomic and social aspects of cancer patients' lives [53-59].
A study conducted previously by our research group in
954 adult cancer patients found that after controlling for
the effects of age and prior treatment history, deteriora-
tion in fatigue was statistically significantly associated
with declines in health and physical, social and economic,
Table 7: Univariate analysis of QoL predictors of patient 
satisfaction
QLQ-C30 Scale % of patients "very satisfied" P - Value
Below Median Above Median
Global 88.8 94.6 0.03
Physical 88.3 95.0 0.01
Role 88.0 95.9 0.002
Emotional 91.7 92.3 0.79
Cognitive 90.0 94.7 0.07
Social 88.0 95.9 0.002
Fatigue 96.3 85.3 0.001
Nausea/Vomiting 94.7 87.0 0.005
Pain 94.6 89.3 0.04
Dyspnea 92.5 91.3 0.64
Insomnia 92.6 91.7 0.73
Appetite Loss 95.5 87.4 0.002
Constipation 92.9 90.4 0.37
Diarrhea 93.0 89.3 0.21
Financial Difficulty 94.9 89.1 0.01
Table 8: Multivariate logistic regression of predictors of patient satisfaction without controlling for demographic and clinical variables
Variables Odds Ratio 95% Confidence Interval P - Value
Physical 0.88 0.32 to 2.44 0.81
Role 1.17 0.36 to 3.82 0.80
Social 1.49 0.54 to 4.12 0.44
Fatigue 0.29 0.10 to 0.88 0.03
Nausea/vomiting 0.71 0.31 to 1.65 0.43
Pain 1.40 0.54 to 3.66 0.49
Appetite loss 0.60 0.25 to 1.44 0.25
Financial difficulty 0.61 0.28 to 1.34 0.22
Global health 0.71 0.28 to 1.85 0.49
Constant 326.15 0.01BMC Health Services Research 2009, 9:190 http://www.biomedcentral.com/1472-6963/9/190
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psychological and spiritual, family, and global QoL[57].
Similarly, in a study of 1957 breast cancer survivors,
fatigue was found to be significantly associated with high
levels of depression, pain and sleep disturbance[55]. In
another study conducted in 54 patients receiving adjuvant
chemotherapy for breast cancer, fatigue showed strong
significant correlations with emotional upset, muscle
weakness, pain, numbness, sleep problems, problems
with concentration and heartburn before the start of
chemotherapy[58]. In a study conducted in a group of
cancer patients undergoing radiotherapy, fatigue was
associated with poor QoL. This association was consider-
ably lower before treatment than at post-treatment or fol-
low-up assessment, suggesting that fatigue becomes most
important when treatment has ended[59]. The principal
finding of our current study that fatigue independently
predicts patient satisfaction takes the research on fatigue
in cancer to the next level. Fatigue which is known to have
an impact of QoL can also predict patient satisfaction,
thereby, making it an important health care measure to
evaluate and address.
In order to put our study in a better context of the existing
literature, we also briefly review here several studies which
have investigated the determinants of patient satisfaction
in a variety of cancer care settings. A study conducted in
647 cancer patients using the EORTC IN-PATSAT32 ques-
tionnaire found that patients with a higher level than
compulsory education or with a lower than a university
education level reported lower overall satisfaction;
patients reporting lower overall satisfaction were treated
in a medical ward and had major compared to minor
treatment toxicity. Patients with a relatively higher level of
global health status reported higher level of satisfaction
with doctors' and nurses' interpersonal skills, information
provision and availability. In terms of satisfaction with
care overall, patients treated in non-academic settings
reported higher overall satisfaction compared to patients
treated in academic/teaching settings [23]. Similarly,
another study done in 2021 cancer patients at a special-
ized cancer hospital in Norway found that performance of
nurses and physicians, level of information perceived,
outcome of health status, reception at the hospital, older
age and anxiety independently predicted 'patient satisfac-
Table 9: Multivariate logistic regression of predictors of patient satisfaction after controlling for demographic and clinical variables
Variables Odds Ratio 95% Confidence Interval P - Value
Age 1.04 0.99 to 1.08 0.16
Gender 0.83 0.28 to 2.53 0.78
Prior treatment history 0.81 0.34 to 1.92 0.62
Tumor type 0.24
Stage at diagnosis 0.59 0.23 to 1.50 0.26
Physical 1.56 0.47 to 5.14 0.47
Role 0.93 0.24 to 3.57 0.92
Social 1.18 0.38 to 3.65 0.77
Fatigue 0.28 0.09 to 0.91 0.03
Nausea/vomiting 0.67 0.26 to 1.72 0.40
Pain 1.61 0.56 to 4.57 0.38
Appetite loss 0.78 0.29 to 2.08 0.62
Financial difficulty 0.58 0.23 to 1.44 0.24
Global health 0.62 0.21 to 1.82 0.38
Constant 141.72 0.13BMC Health Services Research 2009, 9:190 http://www.biomedcentral.com/1472-6963/9/190
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tion'[60]. Yet another study conducted in 2790 patients
found that males, older and healthier patients tend to rate
the overall quality of care higher than female, younger,
and less healthy patients. Patients with prostate cancer
tend to rate the overall quality of care higher than those
with other cancer types [25]. Another study done in 2247
cancer patients in Ontario found that patients hospital-
ized once during the past 2 years reported significantly
higher quality of care than those hospitalized three and
four times (P < 0.05). Also, less healthy cancer patients
(self-assessed health) tend to judge the quality of care
lower than healthier cancer patients[45].
The results of our study do not compare directly with
above mentioned studies because of the differences in
study design, patient population studied, questionnaire
used and outcome measures. Nevertheless, our study adds
useful information to the growing body of literature on
the importance of evaluating the predictors of patient sat-
isfaction in oncology. Prospective studies evaluating the
importance of QoL assessment and intervention on
patient satisfaction should be carried out in a large popu-
lation of cancer patients. Such studies will help us reach
definitive conclusions on the role of QoL in improving
patient satisfaction with overall cancer care. We are in the
process of implementing a real-time computerized QoL
collection and reporting system at our hospital, which will
allow physicians to keep up to date with a patient's
progress on QoL. A score below what is considered nor-
mal on any QoL domain would prompt specific action by
the healthcare team.
Although this study reports on a relatively uncommon
analysis of predicting patient satisfaction with QoL meas-
ures, several limitations of the study require acknowledg-
ment. The patient cohort was limited to only those
patients who were English speakers, so this study sample
is therefore not broadly representative of cancer patients
in general. The response rate for the study was relatively
low compared to that reported in the literature [61]. This
is because a significant fraction of the data was collected
via a mailed survey. However, there was no difference in
patient satisfaction by mode of data collection. The data
we used for this study was not primarily meant for
research purpose. CTCA is a unique medical center. It spe-
cializes in treating only cancer patients, and it has an
intense focus on patient-centered care. Patients report very
high levels of satisfaction with their care at CTCA. These
results will not necessarily generalize to quality of life and
its effects on cancer patient satisfaction with their care at
general medical centers and hospitals. Patients in this
study reported on their quality of life and satisfaction dur-
ing or just after their first visit to CTCA. Thus, the results
may or may not generalize to long-term patient satisfac-
tion for patients undergoing care for cancer. Patient denial
of dissatisfaction with health care may have influenced
the results of this study [62]. Workers in the field of
patient satisfaction have observed that patients may not
express dissatisfaction with the provision of health care
because of concern that the standard of care may deterio-
rate. In the event that such denial did occur in the study,
the reported results overestimate the extent of patient sat-
isfaction. This study used a non-validated patient satisfac-
tion questionnaire. Finally, resilience might contribute to
some of the findings observed in our study.
Our study has several strengths. We surveyed a large sam-
ple size of different cancer types. In determining patient
satisfaction, the emphasis of care is generally on curing
the patient and treating the disease rather than addressing
the QoL of the patient and acknowledging the personal
and social needs. It is well-documented that patient's psy-
chosocial, social and financial needs [63-66], should also
be taken into consideration and health care providers
should be trained in adequate skills required to satisfy
such needs.
Conclusion
In summary, our study has demonstrated the predictive
significance of fatigue in evaluating patient satisfaction in
oncology. To the best of our knowledge, this study is the
first in the literature to report on the role of QoL as a pre-
dictor of patient satisfaction in a large heterogeneous sam-
ple of cancer patients.
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